Dr. Ara Khachaturian
Expert clinical strategist with 30+ years of experience guiding neuroscience and public health programs through complex research, policy, and evidence-generation decision points.
Dr. Ara Khachaturian brings deep expertise in epidemiology, biomedical research strategy, and advanced data modeling applied to neurological disease and public health. He has advised research institutions, policymakers, and scientific organizations on evidence generation, population-level disease modeling, and translational research strategy; particularly for complex neurodegenerative conditions such as Alzheimer’s disease where clinical, epidemiological, and policy considerations must align.
Areas of Focus / Expertise
- Epidemiology and population health modeling
- Clinical research strategy for neurodegenerative diseases
- Evidence generation frameworks for public health and prevention programs
- Advanced computational modeling and high-performance computing in biomedical research
- Research program design and scientific advisory leadership
- Scientific publishing, peer review, and research dissemination
- Strategic planning for large-scale neurological disease initiatives
Selected Experience & Impact
Over the course of his career, Dr. Khachaturian has played a central role in shaping Alzheimer’s disease research and prevention strategy. As Executive Vice-President of Prevent Alzheimer’s 2020, Inc., he has helped advance initiatives focused on early detection and prevention of neurodegenerative disease. He is the founding Executive Editor of the Alzheimer’s & Dementia journal series, a leading publication platform for Alzheimer’s research, and has contributed to the development and dissemination of influential scientific work in the field.
Background & Credentials
Prior to FDA Partners, Dr. Khachaturian held leadership roles in public health research, biomedical policy, and scientific publishing. He currently serves as a Senior Research Fellow at the National Supercomputing Institute at the University of Nevada, Las Vegas, where he applies high-performance computing and advanced modeling techniques to health sciences research. He holds a PhD and has dedicated his career to advancing research and policy approaches for neurological disease prevention and treatment.
Dr. Khachaturian brings a population-level perspective to biomedical innovation, helping organizations connect scientific discovery, clinical research, and public health strategy.